Search

Pages

1. • Journal article

   • 

   A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

   Farmer, Pierre Bonnefoi, Herve[UCL] Anderle, Pascale Cameron, David Wirapati, Pratyakasha Becette, Veronique Andre, Sylvie Piccart, Martine Campone, Mario Brain, Etienne MacGrogan, Gaetan Petit, Thierry Jassem, Jacek Bibeau, Frederic Blot, Emmanuel Bogaerts, Jan[UCL] Aguet, Michel Bergh, Jonas Iggo, Richard Delorenzi, Mauro (2009) Nature Medicine — Vol. 15, no. 1, p. 68-74 (2009)
2. • Journal article

   • 

   Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

   Giuliani, Rosa Durbecq, Virginie Di Leo, Angelo Paesmans, Marianne Larsimont, Denis Leroy, Jean-Yves Borms, Marleen Vindeuoghel, Anita Jerusalem, Guy D'Hondt, Véronique[UCL] Dirix, Luc Canon, Jean-Luc Richard, Vincent Cocquyt, Veronique Majois, Francoise Reginster, Michel Demol, Jan Kains, Jean-Pierre Delree, Paul Keppens, Carine Sotiriou, Christos Piccart, Martine Cardoso, Fatima (2007) European Journal of Cancer — Vol. 43, no. 4, p. 725-735 (2007)
3. • Journal article

   • 

   Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, investigational drug branch for breast cancer and the new drug development group study

   Bottomley, Andrew Biganzoli, Laura Cufer, Tanja Coleman, Robert E. Coens, Corneel Efficace, Fabio Calvert, Hilary Allan Gamucci, Teresa Twelves, Chris Fargeot, Pierre Piccart, Martine (2004) Journal of Clinical Oncology — Vol. 22, no. 13, p. 2576-2586 (2004)
4. • Journal article

   • 

   Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.

   Venet, David Fimereli, Danai Rothé, Françoise Boeckx, Bram Maetens, Marion Majjaj, Samira Rouas, Ghizlane Capra, Maria Bonizzi, Giuseppina Contaldo, Federica Galant, Christine[UCL] Piccart, Martine Pruneri, Giancarlo Larsimont, Denis Lambrechts, Diether Desmedt, Christine Sotiriou, Christos (2020) EBioMedicine — Vol. 56, p. 102793 [1-8] (2020)
5. • Journal article

   • 

   Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

   Saura, Cristina Hlauschek, Dominik Oliveira, Mafalda Zardavas, Dimitrios Jallitsch-Halper, Anita de la Peña, Lorena Nuciforo, Paolo Ballestrero, Alberto Dubsky, Peter Lombard, Janine M Vuylsteke, Peter[UCL] Castaneda, Carlos A Colleoni, Marco Santos Borges, Giuliano Ciruelos, Eva Fornier, Monica Boer, Katalin Bardia, Aditya Wilson, Timothy R Stout, Thomas J Hsu, Jerry Y Shi, Yi Piccart, Martine Gnant, Michael Baselga, José de Azambuja, Evandro (2019) The Lancet. Oncology — Vol. 20, no.9, p. 1226-1238 (2019)
6. • Journal article

   • 

   Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.

   Delaloge, Suzette Piccart, Martine Rutgers, Emiel Litière, Saskia van 't Veer, Laura J van den Berkmortel, Franchette Brain, Etienne Dudek-Peric, Aleksandra Gil-Gil, Miguel Gomez, Patricia Hilbers, Florentine S Khalil, Zaman Knox, Susan Kuemmel, Sherko Kunz, Georg Lesur, Anne Pierga, Jean-Yves Ravdin, Peter Rubio, Isabel T Saghatchian, Mahasti Smilde, Tineke J Thompson, Alastair M Viale, Giuseppe Zoppoli, Gabriele Vuylsteke, Peter[UCL] Tryfonidis, Konstantinos Poncet, Coralie Bogaerts, Jan Cardoso, Fatima MINDACT investigators and the TRANSBIG Consortium (2020) Journal of clinical oncology — Vol. 38, no. 11, p. 1186-1197 (2020)
7. • Journal article

   • 

   ESR1 mutations in metastatic lobular breast cancer patients.

   Desmedt, Christine Pingitore, Julien Rothé, Françoise Marchio, Caterina Clatot, Florian Rouas, Ghizlane Richard, François Bertucci, François Mariani, Odette Galant, Christine[UCL] Fribbens, Charlotte O'Leary, Ben van den Eynden, Gert Salgado, Roberto Turner, Nicholas C Piccart, Martine Vincent-Salomon, Anne Pruneri, Giancarlo Larsimont, Denis Sotiriou, Christos (2019) NPJ breast cancer — Vol. 5, p. 9 [1-7] (2019)
8. • Journal article

   • 

   Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer

   Kramer, JA Curran, D Piccart, Martine de Haes, JCJM Bruning, P Klijn, J Van Hoorebeeck, I Paridaens, Robert[UCL] (2000) European Journal of Cancer — Vol. 36, no. 12, p. 1498-1506 (2000)
9. • Journal article

   • 

   Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist

   Kramer, JA Curran, D Piccart, Martine de Haes, JCJM Bruning, PF Klijn, JGM Bontenbal, M van Pottelsberghe, C Groenvold, M Paridaens, Robert[UCL] (2000) European Journal of Cancer — Vol. 36, no. 12, p. 1488-1497 (2000)
10. • Journal article

    • 

    Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer

    Efficace, Fabio Biganzoli, Laura Piccart, Martine Coens, Corneel Van Steen, Kristel Cufer, Tanja Coleman, Robert E. Calvert, Hilary Allan Gamucci, Teresa Twelves, Chris Fargeot, Pierre Bottomley, Andrew (2004) European Journal of Cancer — Vol. 40, no. 7, p. 1021-1030 (2004)
11. • Journal article

    • 

    Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide plus filgrastim as neoadjuvant treatment in locally advanced breast cancer: An EORTC-NCIC-SAKK multicenter study

    Therasse, Patrick Mauriac, L Welnicka-Jaskiewicz, M Bruning, P Cufer, T Bonnefoi, Herve Tomiak, E Pritchard, KI Hamilton, A Piccart, Martine (2003) Journal of Clinical Oncology — Vol. 21, no. 5, p. 843-850 (2003)
12. • Journal article

    • 

    Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium

    Neymark, N. Gorlia, Thierry[UCL] Adriaenssen, I Baron, B Piccart, Martine (2002) PharmacoEconomics — Vol. 20, no. 7, p. 485-497 (2002)
13. • Journal article

    • 

    Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival

    Piccart, Martine Vansteenkiste, Johan Prenen, Hans Duhoux, François[UCL] Janssens, Ann Delforge, Michel Awada, Ahmad Neven, Patrick Sibille, Anne Neyns, Bart (2023) Belgian Journal of Medical Oncology — Vol. 17, no.6, p. 211-5 (2023)
14. • Speech

    • 

    Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.

    Hendlisz, Alain Caparica, Rafael Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jozef Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Vermeij, Joanna D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Buggenhout, Alexis Paesmans, Marianne Piccart, Martine Flamen, Patrick (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —
15. • Journal article

    • 

    Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

    Gómez-Aleza, Clara Nguyen, Bastien Yoldi, Guillermo Ciscar, Marina Barranco, Alexandra Hernández-Jiménez, Enrique Maetens, Marion Salgado, Roberto Zafeiroglou, Maria Pellegrini, Pasquale Venet, David Garaud, Soizic Trinidad, Eva M Benítez, Sandra Vuylsteke, Peter[UCL] Polastro, Laura Wildiers, Hans Simon, Philippe Lindeman, Geoffrey Larsimont, Denis Van den Eynden, Gert Velghe, Chloé Rothé, Françoise Willard-Gallo, Karen Michiels, Stefan Muñoz, Purificación Walzer, Thierry Planelles, Lourdes Penninger, Josef Azim, Hatem A Loi, Sherene Piccart, Martine Sotiriou, Christos González-Suárez, Eva (2020) Nature communications — Vol. 11, no.1, p. 6335 [1-18] (2020)
16. • Journal article

    • 

    Genomic grade adds prognostic value in invasive lobular carcinoma

    Metzger-Filho, O Michiels, S Bertucci, F Catteau, A Salgado, R Galant, Christine[UCL] Fumagalli, D Singhal, S K Desmedt, C Ignatiadis, M Haussy, S Finetti, P Birnbaum, D Saini, K S Berlière, Martine[UCL] Veys, I de Azambuja, E Bozovic, I Peyro-Saint-Paul, H Larsimont, D Piccart, Martine Sotiriou, C (2013) Annals of Oncology — Vol. 24, no.2, p. 377-384 (2013)
17. • Journal article

    • 

    Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

    Curran, D. Aaronson, Neil K. Standaert, B. Molenberghs, G. Therasse, Patrick Ramirez, A. Koopmanschap, M. Erder, H. Piccart, Martine (2000) European Journal of Cancer — Vol. 36, no. 7, p. 834-844 (2000)
18. • Journal article

    • 

    Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.

    Debien, Veronique Marta, Guilherme Nader Agostinetto, Elisa Sirico, Marianna Jacobs, Flavia Molinelli, Chiara Moreau, Michel Paesmans, Marianne De Giorgi, Ugo Santoro, Armando Taylor, Donatienne[UCL] Duhoux, François[UCL] Botticelli, Andrea Barchiesi, Giacomo Speranza, Iolanda Lambertini, Matteo Wildiers, Hans Azambuja, Evandro de Piccart, Martine (2023) Critical reviews in oncology/hematology — Vol. 190, p. 104089 (2023)
19. • Journal article

    • 

    D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC gynaecological cancer co-operative group study

    Duffaud, F van der Burg, MEL Namer, M Vergote, Ignace[UCL] Willemse, PHB Huinink, WT. Guastalla, JP. Nooij, MA Kerbrat, P Piccart, Martine Tumolo, Salvatore Favalli, G van der Vange, N Lacave, AJ. Wils, J. Splinter, TAW. Einhorn, N Roozendaal, KJ Rosso, R Vermorken, JB. (2001) Anti-Cancer Drugs : international journal on anti-cancer agents — Vol. 12, no. 2, p. 159-162 (2001)
20. • Speech

    • 

    Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: An international multicenter study

    Efficace, Fabio Therasse, Patrick Piccart, Martine Coens, Corneel Van Steen, Kristel Welnicka-Jaskiewicz, Marzena Cufer, Tanja Dyczka, Jaroslaw Lichinitser, Michail Shepherd, Lois de Haes, Hanneke Sprangers, Mirjam A. Bottomley, Andrew (2004) 40th Annual Meeting of the American-Society-of-Clinical-Oncology — New Orleans(La)
21. • Journal article

    • 

    EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): 5 years of European collaboration in new drug development for breast cancer

    Awada, A. VanVreckem, A Paridaens, Robert[UCL] Bruning, PF Klijn, J Tomiak, E Vinholes, J Roy, JA Kusenda, Z Boes, GH Vanglabbeke, M. Piccart, Martine (1997) European Journal of Cancer — Vol. 33, no. 8, p. 1173-1176 (1997)
22. • Speech

    • 

    Preoperative Axillary Immunolymphoscintigraphy (ilsc) in Breast-cancer Patients Using a 123-iodine Labeled Monoclonal-antibody (ab)

    Fruhling, J. Delcorde, André[UCL] Balikdjian, D. Leclef, B. Larsimont, D. Nogaret, JM. Mattheiem, W. Piccart, Martine Verbist, A. Trouet, André[UCL] (1992) European Association of Nuclear Medicine Congress — Lisbonne
23. • Speech

    • 

    SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)

    Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphaël Peeters, Marc Holbrechts, Stéphane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand Van Laethem, Jean Luc Ceyssens, Sarah Barbuto, Anna Maria Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Paesmans, Marianne Piccart, Martine Flamen, Patrick (2012) ASCO Annual Meeting — Chicago, Illinois
24. • Journal article

    • 

    Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.

    Desmedt, Christine Demicheli, Romano Fornili, Marco Bachir, Imane Duca, Mariana Viglietti, Giulia Berlière, Martine[UCL] Piccart, Martine Sotiriou, Christos Sosnowski, Maurice Forget, Patrice Biganzoli, Elia (2018) Journal of the National Cancer Institute — Vol. 110, no.10, p. 1115-1122 (2018)
25. • Journal article

    • 

    A Phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors

    Van Den Neste, Eric[UCL] De Valeriola, Dominique Kerger, Joseph[UCL] Bleiberg, Harry Kusenda, Zlatko Brassinne, Christiane Bartholomeus, Sylvie Selleslags, Jean Hennebert, Philippe[UCL] Wythouck, Hilda Cazenave, Isabelle Lefresne-Soulas, Florence Piccart, Martine (2000) Clinical Cancer Research — Vol. 6, no. 1, p. 64-71 (2000)

Pages